Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years

Arthritis Research & Therapy - Tập 7 - Trang 1-1 - 2005
X Baraliakos1, J Brandt1, J Listing2, J Sieper3, J Braun1
1Rheumatology Medical Center Ruhrgebiet, Herne, Germany
2German Rheumatism Research Center, Berlin, Germany
3University Medicine Berlin, Campus Benjamin Franklin, Germany

Thông tin
Thông tin xuất bản

Arthritis Research & Therapy

Tập 7

1-1

Thông tin tác giả